Pharma/Biotech – USA, Europe, Asia and ROW Regulatory News – Feb 2025
USA
FDA Approves First Rapid‑Acting Insulin Biosimilar for Diabetes
The FDA has approved Merilog (insulin‑aspart‑szjj), a biosimilar to Novolog (insulin aspart), for improving glycemic control...
Asia Biotech, Biotech 2025, Biotech Insights, Biotech Updates, Europe Pharma, Pharma News, Pharma Regulations, Pharma Trends, Regulatory Affairs, ROW Regulatory, USA Regulations